The University of Bristol and spin-out company Imophoron Ltd have announced they are ready to test COVID-19 vaccine candidates in a pre-clinical programme. Following the successful creation of a thermostable vaccine candidate for the chikungunya virus, the bio-engineered protein (known as the ADDOmer©) will also be tested on the coronavirus.
Read the article:
New vaccine platform used to develop COVID-19 candidates
